Advertisement

Sequential Regional Hyperthermia: A Possible Answer for the Treatment of Cancer

  • John M. Rude’
  • Howard L. Mark
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 157)

Abstract

A therapeutic rationale for the treatment of metastatic cancer is presented which incorporates the use of deep regional hyperthermia of major body areas such as the thorax and abdomen. These body areas would be treated sequentially with the goal of eliminating the problems inherent to whole-body hyperthermia. To achieve this goal, a tri-modality approach is considered which combines regional deep heating with regional X-ray therapy and with drug therapy using agents which are heat as well as radiation hypoxic cell sensitizers (Nitroimidazoles or glucose analogues). The rationale for such an approach is well founded at the basic research level. The benefit of the tri-modality approach is that therapeutic levels of drug, X-rays and heat can be reduced significantly and hopefully be non-toxic.

Keywords

Metastatic Cancer Glucose Analogue Therapeutic Rationale Initial Clinical Trial Lung AdCa 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Arcangeli, G., Barni, E., Cividalli, A., Mauro, F., Morelli, D., Nervi, C., Spano, M., and Tatocchini, A. Effectiveness of Microwave Hyperthermia Ccmbined with Ionizing Radiation: Clinical Results on Neck Node Metastases. Int. J. Radiation Oncology Biol. Phys. 6: 143–148, 1980.CrossRefGoogle Scholar
  2. 2.
    Ash, D. V., Smith, M. R., and Bugden, R. D. Distribution of Misonidazole in Human Tumors and Normal Tissues. Br. J. Cancer 39: 503–509, 1979.PubMedCrossRefGoogle Scholar
  3. 3.
    Bicher, H. I., Sandhu, T. S., and Hetzel, F. W. Hyperthermia and Radiation in Combination: A Clinical Fractionation Regime. Int. J. Radiation Oncology Biol. Phys. 6: 867–870, 1980.CrossRefGoogle Scholar
  4. 4.
    Goldfeder, A., Brown, D. M. and Berger, A. Enhancement of Radioresponse of a Mouse Mammary Carcinoma to Combined Treatments with Hyperthermia and Radiosensitizer Misonidazole. Cancer Research 39: 2966–2970, 1979.PubMedGoogle Scholar
  5. 5.
    Grier, R. L., Brewer, W. G., and Theilen, G. H. Hyperthermic Treatment of Superficial Tumors in Cats and Dogs. J. Amer. Veter. Med. Assoc. 177: 227–233, 1980.Google Scholar
  6. 6.
    Hofer, K. G., MacKinnon, A. R., Schubert, A. L., Lehr, J. E. and Grimmett, E. V. Radiosensitization of Tumors and Normal Tissues by Combined Treatment with Misonidazole and Heat. Submitted for publication, 1981.Google Scholar
  7. 7.
    Holt, J. A. G. Alternative Therapy for Recurrent Hodgkins Disease. British J. Radiology 53: 1061–1067, 1980.CrossRefGoogle Scholar
  8. 8.
    Hornback, N. O., Shupe, R. E., Shidnia, H., Joe, B. T., Sayoc, E. and Marshall, C. Preliminary Clinical Results of Combined 433 Megahertz Microwave Therapy and Radiation Therapy on Patients with Advanced Cancer. Cancer 40: 2854–2863, 1977.PubMedCrossRefGoogle Scholar
  9. 9.
    Kim, J. H., Hahn, E. W., and Tokita, N. Combination Hyperthermia and Radiation Therapy for Cutaneous Malignant Melanoma. Cancer 41: 2143–2148, 1978.PubMedCrossRefGoogle Scholar
  10. 10.
    Kligerman, M. M., Shaw, M. T., Slavik, M. and Yuhas, J. M. Phase I Clinical Studies with WR-2721. Cancer Clin. Trials 3: 217–221, 1980.PubMedGoogle Scholar
  11. 11.
    Landau, B. R., Laszlo, J. S., Stengle, J. and Burk, D. Certain Metabolic and Pharmacologic Effects in Cancer Patients Given Infusions of 2-Deoxy-D-Gluoose. J. Natl. Cancer Inst. 21: 485–494, 1958.PubMedGoogle Scholar
  12. 12.
    Lin, P. S., Kwock, L. and Butterfield, C. E. Diethyldithiocarbamate Enhancement of Radiation and Hyperthermic Effects on Chinese Hamster Cells in Vitro. Radiation Research 77: 501–511, 1979.PubMedCrossRefGoogle Scholar
  13. 13.
    Marmor, J. B. and Hahn, G. M. Combined Radiation and Hyperthermia in Superficial Human Tumors. Cancer 46: 1986–1991, 1980.PubMedCrossRefGoogle Scholar
  14. 14.
    Marmor, J. B., Pounds, D., Hahn, N. and Hahn, G. M. Treating Spontaneous Tumors in Dogs and Cats by Ultrasound-Induced Hyperthermia. Int. J. Radiation Oncology Biol. Phys. 4: 967–973, 1978.CrossRefGoogle Scholar
  15. 15.
    Phillips, T. L. Rationale for Initial Clinical Trials and Future Development of Radioprotectors. Cancer Clin. Trials 3: 165–173, 1980.PubMedGoogle Scholar
  16. 16.
    Schuman, V., Song, C. W., Levitt, S. H. Radioprotective Effect of 5-Thio-D-Glucose on Normal Tissues. Abstracts of Papers For The 29th Meeting of the Radiation Research Society, 1981, p. 89.Google Scholar
  17. 17.
    Song, C. W., Kang, M. S., Stettner, S. L., and Levitt, S. H. In Vivo Effect of 5-Thio-D-Glucose on Tumor. In Radiation Sensitizers: Their Use in the Clinical Management of Cancer, L. Brady (Ed.), Massan Publishers, New York, 1980, pp. 296–301.Google Scholar
  18. 18.
    Thrall, D. E., Biery, D. N. and Girardi, A. J. Evaluation of Radiation and WR-2721 in Dogs with Spontaneous Tumors. In Radiation Sensitizers: Their Use in the Clinical Management of Cancer, L. Brady (Ed.), Masson Publishers, New York, 1980, pp. 343–347.Google Scholar
  19. 19.
    White, R. A. S., Workman, P., Owen, L. N. and Bleehen, N. M. The Penetration of Misonidazole into Spontaneous Canine Tumors. Br. J. Cancer 40: 284–293, 1979.PubMedCrossRefGoogle Scholar
  20. 20.
    White, R. A. S., Workman, P., Freedman, L. S., Owen, L. N. and Bleehen, N. M. The Pharmacokinetics of Misonidazole in the Dog. Europ. J. Cancer 15: 1233–1242, 1979.CrossRefGoogle Scholar
  21. 21.
    Wasserman, T. H., Stetz, J. and Phillips, T. L. Radiation Therapy Oncology Group Clinical Trials with Misonidazole. Cancer 47: 2382–2390, 1981.PubMedCrossRefGoogle Scholar
  22. 22.
    Yau, T. M., and Kim, S. C. Local Anaesthetics as Hypoxic Radiosensitizers, Oxic Radioprotectors and Potentiators of Hyperthermic Killing in Mammalian Cells. British J. Radiology 53: 587–692, 1960.Google Scholar
  23. 23.
    Yuhas, J. M. A More General Role For WR-2721 in Cancer Therapy Br. J. Cancer 41: 832–834, 1980.PubMedCrossRefGoogle Scholar
  24. 24.
    Yuhas, J. M., Spellman, J. M. and Culo F. The Role of WR-2721 in Radiotherapy and/or Chemotherapy. Cancer Clin. Trials 3: 211–216, 1980.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • John M. Rude’
    • 1
  • Howard L. Mark
    • 1
  1. 1.CompuMed, Inc.Los AngelesUSA

Personalised recommendations